Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

ERAS versus standard perioperative care for parent-infant bonding after cesarean delivery

Official title: The Effect of the Cesarean ERAS Protocol on Mother-Infant and Father-Infant Bonding: a Multicenter, Randomized Controlled Clinical Trial.

Run by Okan University · NCT07276126 · Data updated 2026-11-12

This trial will test whether using the ERAS protocol after cesarean helps mothers and fathers bond with their newborns compared with standard perioperative care.

More Cesarean Section trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment1 (estimated)
SponsorOkan University
Academic / other
Locations1 site (Istanbul)
StatusRecruiting
StartedDecember 13, 2025
Main results expectedFebruary 20, 2026
Study endsApril 20, 2026
Registry record updatedApril 28, 2026
Trial IDNCT07276126 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are Turkish-speaking pregnant women aged 18–60 with a singleton, term (≥37 weeks) pregnancy undergoing elective or indicated cesarean delivery whose partners are willing to complete postpartum questionnaires.

Probably not a fit

Patients with preterm birth, major neonatal complications requiring prolonged NICU care, severe maternal obstetric complications (e.g., massive hemorrhage, hysterectomy, severe preeclampsia/eclampsia), active severe psychiatric disorder, or inability to complete Turkish questionnaires are unlikely to benefit from the study intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, parallel-group trial compares an Enhanced Recovery After Surgery (ERAS) protocol to standard perioperative care for women undergoing cesarean delivery, starting at Istanbul Okan University Hospital and expanding to additional centers after site preparation. Participants are randomized 1:1 to ERAS—which includes preoperative education, multimodal analgesia, early oral intake, early mobilization, and early catheter removal—or to usual care, and fathers are invited to participate in bonding assessments. The primary outcome is mother-infant bonding measured by the Postpartum Bonding Questionnaire (PBQ) on postpartum day 7, with secondary outcomes including early attachment scales and Edinburgh Postnatal Depression Scale scores at 2 hours, 24 hours, day 4, and day 7. The design aims to capture early psychosocial effects of perioperative pathways on both maternal and paternal bonding.

Why it matters

Potential benefit: If successful, ERAS could improve early mother-infant and father-infant bonding while supporting faster physical recovery and potentially lowering postpartum mood problems.

How similar studies have gone: ERAS has documented benefits for physical recovery and reduced opioid use in obstetrics in pilot and observational reports, but randomized evidence showing improved parent-infant bonding is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
IInclusion Criteria:

Pregnant women aged 18-60 years.

Singleton, live fetus, and ≥37 weeks of gestation.

Undergoing elective or medically indicated cesarean delivery.

Ability to read and understand Turkish (for questionnaire validity).

Mothers and fathers willing and able to complete postpartum follow-up assessments (2 hours, 24 hours, day 4, day 7).

Provision of written informed consent by mother and, if participating, by father/partner.

Maternal postpartum clinical stability (no condition precluding questionnaire completion).

❌ Exclusion Criteria (Dışlanma Kriterleri)

Exclusion Criteria:

Preterm birth (\<37 weeks) or multiple gestation (twins, triplets).

Stillbirth, early neonatal death, or major congenital anomaly.

Newborn requiring prolonged NICU stay preventing bonding assessments.

Maternal severe obstetric complications:

Massive postpartum hemorrhage

Hysterectomy

Severe preeclampsia or eclampsia

Severe postpartum infection

Maternal active psychiatric disorder or use of psychotropic medication.

Maternal need for high-dose opioid analgesia or sedation interfering with bonding assessments.

Inability to read/understand Turkish or cognitive impairment preventing questionnaire completion.

Failure to complete follow-up visits (2 hours, 24 hours, day 4, day 7).

Withdrawal of consent at any time.

Where it's running

  • Istanbul Okan University Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.